Kyverna Therapeutics

Associate Director, Clinical Data Management

Kyverna Therapeutics  •  $175k - $195k/yr  •  Remote  •  15 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.

Title Associate Director, Clinical Data Management
Reports to: Executive Director, Clinical Data Management
Location Remote

The AD, Clinical Data Management (CDM) is responsible for leading and overseeing clinical data management activities across assigned clinical studies to ensure the delivery of high-quality, regulatory-compliant, and inspection-ready clinical data. This individual will provide strategic and operational leadership for end-to-end data management activities from study start-up through database lock and submission support.

Operating in a fast-paced, growth-stage environment, the Associate Director will partner closely with Clinical Operations, Biostatistics, Statistical Programming, Clinical Development, Regulatory, Quality, and external vendors to drive efficient and scalable data management processes, standards, and technologies. This role will contribute to the evolution of Kyverna’s CDM infrastructure and operating model while supporting multiple studies across the clinical development portfolio.

Responsibilities

  • Lead end-to-end Clinical Data Management activities for assigned clinical studies from study start-up through database lock and archival
  • Provide operational leadership for study timelines, deliverables, risks, and quality across internal teams and external vendors
  • Oversee key CDM activities including: Database build and validation, eCRF design and review, Edit check specifications, Data review and cleaning, External data reconciliation (e.g., PK, biomarkers, central labs, imaging),, Database lock activities, Data transfers for statistical analysis and regulatory submissions
  • Review and approve key CDM documentation including: Data Management Plans (DMPs), Data Review Plans, CRF Completion Guidelines, Vendor data transfer specifications, Database validation documentation
  • Ensure clinical data are accurate, complete, consistent, and inspection-ready in compliance with timelines and regulatory requirements
  • Partner cross-functionally with Clinical Operations, Biostatistics, Statistical Programming, Clinical Development, Regulatory, and Quality to support study execution and submission readiness
  • Contribute to the development and implementation of CDM standards, SOPs, processes, and best practices
  • Support standardization initiatives aligned with CDISC standards and evolving industry practices
  • Drive proactive risk identification, issue escalation, and resolution across study teams and vendors
  • Lead and manage CRO/vendor relationships for data management activities, including oversight of quality, timelines, budgets, and performance metrics
  • Support governance meetings and vendor performance reviews to ensure accountability and continuous improvement
  • Collaborate with cross-functional stakeholders to support data review, reconciliation, and clinical data integrity
  • Support inspection readiness activities, audits, and health authority inspections related to clinical data management
  • Support process optimization, automation, and innovation to improve operational efficiency and data quality
  • Contribute to building a collaborative, high-performing CDM function aligned with company values

Qualifications

  • BS/MS in Life Sciences, Computer Science, Data Management, or related discipline
  • 10+ years of progressive experience in Clinical Data Management within biotech or pharmaceutical industries
  • 3+ years of experience overseeing clinical studies and managing CDM vendors
  • Strong understanding of clinical trial processes, clinical data flows, and global regulatory requirements
  • Working knowledge of CDISC standards, 21 CFR Part 11, and ICH-GCP guidelines
  • Experience managing end-to-end data management activities across Phase 1–3 clinical studies
  • Demonstrated experience overseeing CROs and external vendors in a matrixed environment
  • Experience supporting regulatory submissions and inspection readiness activities
  • Familiarity with EDC systems and data review/reconciliation tools
  • Experience managing external data sources including PK, ADA, biomarkers, imaging, and central laboratory data
  • Strong organizational, problem-solving, and project management skills
  • Excellent communication and cross-functional collaboration skills
  • Ability to effectively prioritize and manage multiple studies in a fast-paced environment
  • Experience in cell therapy or autoimmune disease programs strongly preferred

The national salary range for this position is $175K to $195K USD annually. This salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock plan.

Kyverna Therapeutics

About Kyverna Therapeutics

Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis.

Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Emeryville, California
Year Founded
2018
Social Media